(0.28%) 5 253.50 points
(0.20%) 39 617 points
(0.32%) 18 272 points
(0.69%) $79.81
(-0.48%) $2.29
(1.52%) $2 375.90
(1.05%) $28.66
(1.00%) $1 000.75
(0.11%) $0.928
(-0.37%) $10.83
(-0.01%) $0.798
(-0.16%) $92.40
@ $4.03
Issued: 14 Feb 2024 @ 15:29
Return: -39.95%
Previous signal: Feb 13 - 14:11
Previous signal:
Return: 1.26 %
Live Chart Being Loaded With Signals
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States...
Stats | |
---|---|
Today's Volume | 232 514 |
Average Volume | 727 383 |
Market Cap | 288.51M |
EPS | $0 ( 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.340 |
ATR14 | $0.00300 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-24 | Green Julie | Buy | 240 000 | Stock Option (Right to Buy) |
2024-01-24 | Green Julie | Sell | 110 700 | Stock Option (Right to Buy) |
2024-01-24 | Green Julie | Sell | 97 500 | Stock Option (Right to Buy) |
2024-01-24 | Green Julie | Sell | 160 000 | Stock Option (Right to Buy) |
2024-01-19 | Adimab, Llc | Sell | 5 000 000 | Common Stock |
INSIDER POWER |
---|
7.18 |
Last 36 transactions |
Buy: 9 419 589 | Sell: 5 442 000 |
Volume Correlation
Invivyd, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Invivyd, Inc. Correlation - Currency/Commodity
Invivyd, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.03M (0.00 %) |
EPS: | $-1.810 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-2.03M (0.00 %) |
EPS: | $-1.810 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-462 000 (0.00 %) |
EPS: | $-2.17 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-5.32 |
Financial Reports:
No articles found.
Invivyd, Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators